DCGI grants Bharat Biotech permission  to use the intranasal Covid-19 vaccine for emergency use.

Mandaviya posted on Twitter, saying, “India’s Battle Against COVID-19 Gets a Huge Boost! The @CDSCO INDIA INF has approved Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine for primary COVID-19 immunization in the 18+ age range for very limited usage in emergency situations.”